Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2026-09-29 to 2026-09-29
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Breye Therapeutics A clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases | Series A Verified against 4 of 11 sources | $75.8M | 2026-09-29 | [ PART ] |
AnaCardio A clinical-stage biopharmaceutical company developing novel therapies for heart failure | Series B Verified against 1 of 17 sources | $71.0M | 2026-09-29 | [ PART ] |